CZ Vaccines has the support of the CDTI to carry out R&D projects that finance research related to COVID-19, and our company, in collaboration with the CSIC, has carried out a project in the field of human vaccines called : “INDUSTRIAL DEVELOPMENT OF THE MVA-COVID-19(S) VACCINE CANDIDATE, AGAINST SARS-CoV-2”. This project has been co-financed by the European Regional Development Fund (FEDER), a way of making Europe.
The main objective is to develop the GMP industrial production process of the MVA-COVID-19(S) vaccine candidate obtained by the CNB-CSIC Poxvirus and vaccines group against the SARS-CoV-2 coronavirus.
This project has been carried out at the company's headquarters, in O Porriño, Galicia. Its execution schedule has been between April 2020 and October 2021. The project budget has been €624,759, and we have had the help of the CDTI and the Feder funds.